Moolec Science SA

What they do

Moolec uses genetically engineered plants, a process it calls molecular farming, to produce animal proteins and oils inside crops such as soybeans and safflower. It is a food ingredients company operating in the Food and Kindred Products sector, incorporated in the Cayman Islands with principal executive offices in Rosario, Santa Fe, Argentina. Its ordinary shares and warrants trade on the Nasdaq Stock Market LLC. The company was formed through a business combination involving Moolec Science SA, Bioceres Group, Nutrecon LLC and Nordelis Ventur.

Revenue drivers

• Molecular farming products — The company's business is centered on producing animal proteins and oils in plants as food ingredients. The provided filing excerpt does not disclose revenue figures or product-level relative size.

Recent performance

The excerpt provided does not include income statement figures, revenue, or profitability data. It confirms only that 10,891,761 ordinary shares were issued and outstanding as of June 30, 2025, the fiscal year end covered by the 20-F. No segment revenue, margin, or cash flow figures are available in the provided text.

Strategy

The filing states the company operates through molecular farming, using plants to produce animal proteins and oils for food ingredients. The provided excerpt gives no additional detail on capital investments, product pipeline, partnerships, or commercial priorities beyond the description of the business. Stated direction beyond that is not supported by the provided text.

Risks

• Early-stage technology risk — The company's molecular farming platform uses genetically engineered crops to produce food ingredients, a technology that may face development, scaling, and yield uncertainty.
• Regulatory and approval risk — Genetically engineered food ingredients may require approvals across multiple jurisdictions, and delays or rejections in key markets could limit commercialization.
• Public market and liquidity risk — The company is listed on Nasdaq under MLEC and MLECW and had 10,891,761 ordinary shares outstanding as of June 30, 2025, a small share count relative to many listed peers.
• Foreign private issuer and Cayman incorporation — As a Cayman Islands company filing a Form 20-F with principal executive offices in Rosario, Argentina, it is subject to foreign private issuer rules and cross-border operating considerations.

Outlook

The provided excerpt contains no forward-looking guidance, revenue outlook, or management commentary on future periods. No outlook can be stated beyond the filing's description of the business and the fiscal year end of June 30, 2025.